Le Lézard
Classified in: Health, Business
Subjects: ECO, AVO, CFG

Alzheimer Society welcomes $50 million funding for national dementia strategy


A significant milestone for Canadians living with dementia and their families

TORONTO, March 20, 2019 /CNW/ - The Alzheimer Society of Canada is pleased that the Federal budget released on Tuesday, March 19 will provide $50 million over five years to fund Canada's first national dementia strategy.

Starting this year, the Government of Canada will invest in increased public awareness of dementia through targeted campaigns and activities with a focus on risk reduction, prevention, and combatting the stigma associated with the disease. Investments will also be made in developing treatment guidelines and best practices to promote early diagnosis in cooperation with provincial and territorial partners, as well as understanding the impact of dementia on Canadian communities.

"This investment is great news and we look forward to more robust initiatives as our government builds and implements the national dementia strategy," says Pauline Tardif, CEO at the Alzheimer Society of Canada and Co-chair of the Ministerial Advisory Board on Dementia.

The Alzheimer Society has long advocated for a national dementia strategy and has been working closely with the Minister of Health and the Public Health Agency of Canada in informing the strategy, expected to be announced this spring.

"Our goal ultimately is to see a fully funded and comprehensive national dementia strategy so that Canadian families are well positioned to live as best as possible with dementia, from the point of diagnosis to the end of life," adds Tardif. "This important budget investment is a significant step toward this."

About the Alzheimer Society
The Alzheimer Society is Canada's leading nationwide health charity for people living with Alzheimer's disease and other dementias. Active in communities across Canada, the Society provides information, programs and services, and raises funds for research to better understand the causes of dementia, improve treatment and care, and to find cures.

Quick facts

Download our 2019 pre-budget submission: https://alzheimer.ca/sites/default/files/files/national/advocacy/asc_pre-budget-submission.pdf

SOURCE Alzheimer Society of Canada


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: